Recon: FDA approves Heron’s non-opioid anesthetic; Poll suggests low public trust in US health insti
The Pharma Data
MAY 13, 2021
. Third time’s the charm as Heron wins FDA nod for non-opioid anesthetic Zynrelef ( Endpoints ). Amgen, AstraZeneca bolster their case for breakthrough asthma program as FDA considers taking up a review ( Endpoints ). In Focus: International. Coronavirus Pandemic.
Let's personalize your content